-
News Agency News Aggregator Journalist/Editor Broking House Others
Bliss GVS Pharma Ltd Q3 FY2022-23 consolidated net profit climbs to Rs. 27.94 crores #BlissGVSPharma #Q3FY23 #9MFY23 #ResultUpdate
#BLISSGVS BLISS GVS PHARMA RESULT
BLISSGVS - Board Meeting Outcome For Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine #Part1
BLISSGVS - Appointment Of Chief Financial Officer Of The Company
BLISSGVS - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
BLISSGVS - Clarification W.R.T Submission Of Outcome Of The Board Meeting Held On Monday, November 07, 2022
#BLISSGVS BLISS GVS PHARMA RESULT
Bliss GVS Pharma Ltd Q2FY23 consolidated profit lower at Rs. 13.85 crores #BlissGVSPharma #Q2FY23 #H1FY23 #ResultUpdate
BLISSGVS - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
BLISSGVS - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
BLISSGVS - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
#BLISSGVS 88.45 per gap up open hua…91.30 ka high lagaya…. Keep tracking #BLISSGVS
#BLISSGVS Buy above 87 for the target of 100 / 120 . Keep SL below 79.
Trade Alerts, Trade Ideas and Crypto 🇺🇸
Trading Ideas: BLISSGVS-Breakout/Wait for pullback 📈 FREE trade-of-week via ⟶
BLISSGVS - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
BLISS GVS PHARMA: Q1 CONS NET PROFIT 257.2M RUPEES VS 243M (YOY); 196M (QOQ) || Q1 REVENUE 1.89B RUPEES VS 1.68B (YOY); 1.67B (QOQ) BLISS GVS PHARMA: Q1 EBITDA 388.5M RUPEES VS 346M (YOY) || Q1 EBITDA MARGIN 20.59% VS 20.58% (YOY)
BLISSGVS - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, August 03,2022
BLISSGVS - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
BLISSGVS - Announcement under Regulation 30 (LODR)-Newspaper Publication
-
Connect with us on social media
